HER2-Negative

15 drugs in development·10 companies·1 clinical trial

Drug Pipeline by Phase

Approved(5)

Phase 3(5)

Drug	Company
azd9833	ASTRAZENECA PLC (AZN)
Camizestrant	ASTRAZENECA PLC (AZN)
Giredestrant	ENANTA PHARMACEUTICALS INC (ENTA)
LHRH Agonist	ENANTA PHARMACEUTICALS INC (ENTA)
luteinizing hormone-releasing hormone agonist	ASTRAZENECA PLC (AZN)

Phase 2(3)

Phase 1(1)

Drug	Company
tos-358	MEDICINES CO /DE (MDCO)

Phase 2/Phase 3(1)

Drug	Company
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)

BioSniper tracks 15 drugs in development for HER2-Negative across 10 companies.

There are 1 clinical trial targeting HER2-Negative tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.